New York, USA – October 24, 2023 – Cancer immunotherapy, as an innovative treatment modality, continues to capture growing attention in the scientific community. The industry remains optimistic about the prospect of harnessing the body’s immune system to target and eradicate cancer cells. Creative Biolabs is fully confident in this prospect and aims to provide top-notch research support to scientists and pharmaceutical companies.
“One key aspect of cancer immunotherapy involves the use of immune checkpoint inhibitors, to enhance the immune system’s response against cancer cells,” stated an expert at Creative Biolabs. “The most successful immune checkpoint blockade therapy is anti-PD-1/PD-L1 therapy, which has gained approval for treating a wide variety of cancer types.”
With experience and expertise, Creative Biolabs is excited to delve further into developing small molecule immune checkpoint inhibitors and offers immune checkpoint targeted small molecule drug development services to assist researchers with their immune checkpoint research and drug development goals.
Furthermore, reprogramming macrophages is one of the most promising strategies realized in the field of anti-cancer therapy. Creative Biolabs provides a series of services to support macrophage therapeutic development, ranging from tumor-associated macrophage (TAM) reprogramming services, macrophage isolation and culture services, macrophage polarization assay services, to macrophage marker development services.
Divers TAM reprogramming methods are available at Creative Biolabs, which are listed below:
* Reprogramming TAMs with nanomedicine
Scientists at Creative Biolabs can reprogram TAMs to the M1 phenotype using effective nanomedicine strategies.
* Reprogramming TAMs by targeting signaling pathway
Creative Biolabs employs robust technical pipelines to reprogram TAMs to the M1 phenotype by targeting specific signaling pathways.
* Reprogramming TAMs with anticancer therapies
Custom solutions are offered for clients for clients’ anticancer therapy research projects.
* Reprogramming TAMs by monoclonal antibodies (mAbs)
Comprehensive support is provided for TAM reprogramming using monoclonal antibodies.
Furthermore, Creative Biolabs offers one-stop macrophage marker development services to support global research programs, which adopt several transcriptome-based approaches, including RNAseq, single-cell RNAseq, and microarrays, to identify novel macrophage markers.
To learn more about services for accelerating cancer immunotherapy research at Creative Biolabs, please visit https://macrophage.creative-biolabs.com.
About Creative Biolabs
Established with the mission of advancing biomedical research, Creative Biolabs offers a full range of preclinical services rooted in expertise across different therapeutic areas, including antibody discovery, and new drug development. The company is dedicated to ensuring the timely execution and accuracy of every stage of drug development, meeting the specific requirements of clients’ anti-tumor research programs.
Media ContactCompany Name: Creative BiolabsContact Person: Candy SwiftEmail: Send EmailPhone: 1-631-830-6441Country: United StatesWebsite: https://macrophage.creative-biolabs.com
